Your browser doesn't support javascript.
loading
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.
Hiraki, Masayuki; Maeda, Takahiro; Mehrotra, Neha; Jin, Caining; Alam, Maroof; Bouillez, Audrey; Hata, Tsuyoshi; Tagde, Ashujit; Keating, Amy; Kharbanda, Surender; Singh, Harpal; Kufe, Donald.
Afiliação
  • Hiraki M; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Maeda T; 4Present Address: Department of Gastrointestinal Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871 Japan.
  • Mehrotra N; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Jin C; 2Center for Biomedical, Indian Institute of Technology, Delhi, India.
  • Alam M; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Bouillez A; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Hata T; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Tagde A; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Keating A; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Kharbanda S; 3Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA USA.
  • Singh H; 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA.
  • Kufe D; 2Center for Biomedical, Indian Institute of Technology, Delhi, India.
Signal Transduct Target Ther ; 3: 13, 2018.
Article em En | MEDLINE | ID: mdl-29760958
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2018 Tipo de documento: Article